earli
accur
diagnost
assay
sever
acut
respiratori
syndrom
sar
crucial
infect
control
howev
diagnost
method
avail
today
realtim
revers
transcriptasepolymeras
chain
reaction
rtpcr
requir
second
detect
method
confirm
detect
singl
sequenc
region
sarscoronaviru
sarscov
sensit
accur
earli
diagnosi
report
novel
assay
system
combin
multiplex
rtpcr
diagnost
gene
chip
detect
multipl
virusspecif
genom
sequenc
sarscov
clinic
specimen
success
demonstr
techniqu
offer
highaccuraci
diagnosi
earli
sar
infect
also
semiquantit
assay
sever
acut
respiratori
syndrom
sar
novel
worldwid
infecti
diseas
caus
newli
identifi
coronaviru
sarscov
diseas
rapidli
spread
rel
high
mortal
rate
close
tend
spread
within
hospit
commun
accur
diagnosi
earli
cours
ill
isol
suspect
case
appropri
clinic
care
becom
best
strategi
control
possibl
recurr
sar
outbreak
howev
viral
dynam
pathogenesi
sarscov
vivo
mostli
remain
unknown
believ
incub
period
sar
rang
day
onset
symptom
viral
load
first
week
ill
low
therefor
diseas
stage
patient
may
greatli
affect
diagnost
accuraci
chosen
assay
serolog
test
shown
reliabl
confirm
diagnosi
sarscov
date
two
prevail
serolog
diagnost
method
enzymelink
immunosorb
assay
elisa
indirect
immunofluoresc
assay
ifa
suitabl
sar
diagnosi
viru
titer
rel
high
convalesc
phase
earli
diagnosi
critic
control
diseas
spread
realtim
revers
transcriptasepolymeras
chain
reaction
rtpcr
becom
prevail
option
higher
sensit
detect
lower
viru
titer
earli
infect
nonetheless
pcrbase
assay
identifi
one
region
sarscov
sequenc
per
reaction
suggest
http
wwwwhointcsrsarsdiagnostictestsen
center
diseas
control
prevent
usa
http
wwwcdcgovncidodsarslabdiagnosishtm
detect
one
genom
region
differ
primer
set
anoth
diagnost
method
requir
confirm
sar
infect
overcom
limit
multiplex
rtpcr
mrtpcr
seem
good
altern
simultan
detect
multipl
target
sequenc
region
pathogen
genom
one
assay
sever
respiratori
infecti
diseas
method
report
use
detect
virus
influenza
parainfluenza
respiratori
syncyti
virus
rsv
howev
practic
problem
includ
poor
sensit
specif
limit
method
gener
diagnost
tool
gene
chip
technolog
requir
hybrid
sequencespecif
probe
allow
specif
sensit
detect
target
emerg
power
tool
diagnosi
infecti
pathogen
gene
chip
protocol
also
coupl
pcr
amplif
techniqu
increas
sensit
diagnosi
show
complementari
method
combin
advantag
mrtpcr
gene
chip
system
sar
earli
diagnosi
extract
viral
rna
viral
rna
extract
supernat
fraction
viral
cultur
medium
concentr
determin
use
realartt
hpacoronaviru
lc
rtpcr
reagent
artu
usa
accord
manufactur
instruct
titer
calibr
viral
rna
adjust
copiesml
rna
stock
creat
set
rna
standard
viral
rna
stock
serial
dilut
manner
give
variou
concentr
rang
copiesml
isol
viral
rna
clinic
specimen
throat
swab
clinic
case
collect
contract
hospit
center
diseas
control
taiwan
may
viral
rna
extract
ml
viral
transport
medium
qiaamp
viral
rna
mini
kit
qiagen
usa
accord
manufactur
instruct
elut
ml
rnasefre
water
frozen
use
three
virusspecif
probe
sarscov
design
tabl
align
genom
sequenc
sever
document
strain
sarscov
decid
three
distinct
sequenc
region
conserv
sarscov
strain
uniqu
among
genom
sequenc
speci
avail
genbank
databas
ncbi
addit
three
sarscovspecif
probe
also
design
three
control
probe
rtcp
hcp
ncp
rtpcr
hybrid
neg
control
respect
tabl
six
synthet
oligonucleotid
dissolv
spot
solut
spot
onto
cmtgapst
slide
corn
usa
triplic
produc
cdna
viral
rna
mixtur
ml
extract
viral
rna
pmol
primer
tabl
final
ml
solut
heat
min
cool
ice
min
ad
ml
reaction
mixtur
ml
mmlv
revers
transcriptas
reaction
buffer
promega
inc
usa
ml
dntp
mix
mm
ml
mmlv
revers
transcriptas
u
promega
inc
usa
ml
rnasin
ribonucleas
inhibitor
u
promega
inc
usa
ml
rnasefre
water
revers
transcript
min
pcr
reaction
perform
mix
ml
cdna
previou
revers
transcript
ml
reaction
mixtur
ml
pcr
reaction
buffer
ml
taq
dna
polymeras
ml
dntp
mix
mm
ml
distil
water
amplifi
follow
condit
initi
denatur
min
follow
cycl
final
extens
min
pcr
product
purifi
use
qiaquick
pcr
purif
kit
qiagen
inc
usa
elut
ml
distil
water
elut
cdna
yield
rtpcr
ad
ml
revers
primer
mixtur
pmol
tabl
denatur
min
cool
ice
min
ml
label
reaction
mixtur
ml
klenow
fragment
buffer
takara
bio
inc
japan
ml
klenow
fragment
u
takara
bio
inc
japan
ml
dutp
mix
mm
datp
mm
dctp
mm
dgtp
mm
dttp
ml
mm
amersham
bioscienc
inc
usa
ml
distil
water
ad
denatur
cdna
incub
min
label
label
probe
purifi
use
qiaquick
pcr
purif
kit
qiagen
inc
usa
elut
ml
distil
water
dri
eppendorf
vacufuget
concentr
gene
chip
first
block
prehybrid
solut
formamid
ssc
sd
bsa
min
cdna
resuspend
ml
hybrid
solut
formamid
ssc
sd
mgml
oligonucleotid
mgml
yeast
trna
mgml
salmon
sperm
dna
denatur
boil
water
min
cool
room
temperatur
label
cdna
hybrid
gene
chip
gene
chip
hybrid
h
wash
sequenti
primari
solut
ssc
sd
min
second
solut
ssc
sd
room
temperatur
min
final
solut
ssc
room
temperatur
ethanol
alcohol
rins
gene
chip
dri
compress
air
imag
gene
chip
obtain
use
laser
confoc
slide
scanner
genepix
analyz
use
genepix
pro
softwar
axon
instrument
inc
usa
optim
diagnost
sensit
earli
infect
viral
load
clinic
specimen
still
low
amplifi
copi
number
virusspecif
sequenc
rtpcr
specif
primer
pair
hybrid
detect
gene
chip
analysi
care
select
primer
pair
correspond
differ
region
viral
genom
list
tabl
specif
effici
amplicon
expect
size
detect
nonspecif
band
found
gel
electrophoresi
data
shown
rtpcr
product
label
fluoresc
dye
describ
materi
method
hybrid
sarscov
gene
chip
hybrid
fluoresc
intens
probe
determin
use
laser
confoc
scanner
amplifi
cdna
target
includ
sarscov
control
sequenc
specif
hybrid
correspond
probe
without
notic
crosshybrid
background
figur
evalu
dynam
rang
detect
gene
chip
assay
serial
dilut
calibr
sarscov
rna
copiesml
use
templat
rtpcr
amplif
signal
intens
probe
extract
gene
chip
analysi
figur
show
signal
intens
individu
probe
plot
viral
rna
input
notabl
probe
capabl
detect
pcr
product
theoret
singl
copi
start
sarscov
rna
contrast
appear
less
effici
detect
low
titer
viru
copi
suggest
design
primer
pair
rtpcr
amplif
andor
probe
hybrid
optim
detect
trace
viru
hand
also
note
fluoresc
signal
plateau
earli
low
viru
titer
wherea
seem
exert
wider
linear
dynam
rang
result
suggest
valuabl
quantit
assay
chip
also
note
rtcp
control
probe
show
invari
signal
magnitud
constant
input
control
target
figur
thu
make
use
normal
standard
semiquantif
assay
given
fact
specif
rtpcr
amplif
compat
gene
chip
detect
sarscov
test
feasibl
coupl
mrtpcr
gene
chip
assay
first
optim
concentr
primer
set
rtpcr
condit
provid
highli
effici
rtpcr
amplif
multiplex
reaction
four
primer
set
consist
singl
rtpcr
result
agaros
gel
electrophoresi
analysi
reveal
markedli
amplifi
figur
product
mrtpcr
label
fluoresc
dye
chipbas
detect
result
show
viral
control
probe
specif
hybrid
correspond
probe
figur
particular
pcr
amplicon
undetect
agaros
gel
electrophoresi
figur
becam
detect
probe
gene
chip
figur
clearli
gene
chip
assay
sensit
convent
agaros
gel
electrophoresi
detect
mrtpcr
product
trace
sarscov
potenti
applic
chipbas
assay
clinic
diagnosi
sarscov
infect
evalu
clinic
specimen
studi
throat
swab
randomli
select
differ
patient
either
suspect
probabl
sar
case
center
diseas
control
taiwan
definit
suspect
probabl
case
reli
upon
criteria
http
wwwwhointcsrsarscasedefinitionen
exampl
suspect
case
sar
high
fever
symptom
cough
breath
difficulti
histori
exposur
contact
person
suspect
probabl
case
sar
studi
probabl
case
may
repres
peopl
similar
symptom
suspect
case
except
histori
contact
clear
also
includ
sampl
pool
case
test
singleblind
manner
addit
chipbas
assay
specimen
analyz
parallel
singleround
rtpcr
artu
realtim
nest
pcr
subsequ
confirm
seroconvers
unless
convalesc
sera
avail
due
fatal
case
sera
collect
acut
phase
tabl
summar
accuraci
differ
diagnost
method
chipbas
assay
realtim
nest
pcr
detect
posit
case
clinic
specimen
contrast
case
identifi
sarscovposit
three
miss
singleround
rtpcr
interestingli
determin
three
miss
sampl
contain
copi
viral
genom
test
realtim
nest
pcr
suggest
gene
chip
sensit
method
detect
sarscov
earli
infect
three
case
miss
singleround
rtpcr
artu
anoth
eight
posit
case
total
posit
case
infect
confirm
seroconvers
tabl
quantit
viral
load
clinic
sampl
import
implic
treatment
strategi
establish
semiquantit
model
gene
chip
assay
sarscov
serial
dilut
sarscov
rna
amplifi
mrtpcr
hybrid
gene
chip
figur
dynam
rang
signal
magnitud
probe
differ
viral
rna
input
shown
plot
signal
intens
extract
probe
gene
chip
copi
number
viral
rna
figur
result
reveal
three
viral
probe
exhibit
distinct
linear
rang
sensit
detect
viral
rna
concentr
base
observ
signal
viral
control
probe
statist
analysi
undertaken
establish
quantit
model
averag
signal
intens
rtcp
control
gene
chip
first
adjust
respect
averag
rtcp
control
gene
chip
averag
intens
scpi
gene
chip
normal
accord
adjust
averag
intens
rtcp
control
use
logarithm
base
denot
copi
number
viru
v
normal
averag
intens
scpi
f
scpi
propos
follow
quantit
model
evalu
viral
load
transform
normal
averag
signal
intens
scpi
copi
number
viru
use
leastsquar
method
coeffici
estim
base
data
gener
control
hybrid
result
titrat
sarscov
quantit
model
repres
follow
equat
valu
r
indic
normal
averag
intens
scpi
could
explain
part
variat
result
obtain
hybrid
probebas
detect
use
realart
hpacoronaviru
rtpcr
kit
artu
e
total
nine
sampl
detect
copi
per
test
gene
chip
method
sampl
nest
singleround
pcr
method
viru
copi
number
case
underestim
see
tabl
accordingli
test
model
gene
chip
hybrid
sarscovposit
clinic
sampl
tabl
show
gene
chip
estim
viral
rna
concentr
correl
highli
result
determin
realtim
nest
pcr
plot
chipbas
semiquantit
realtim
nest
pcr
quantit
also
show
good
correl
figur
correl
coeffici
thu
chipbas
assay
provid
qualit
also
semiquantit
diagnosi
sarscov
clinic
specimen
present
studi
report
chipbas
assay
earli
sarscov
infect
test
clinic
specimen
demonstr
gene
chip
accur
detect
sarscov
assay
highli
specif
sensit
applic
clinic
sampl
find
suggest
sever
advantag
convent
singleround
realtim
rtpcr
first
chipbas
assay
highli
sensit
detect
trace
viru
earli
infect
shown
detect
sensit
chipbas
assay
copi
sarscov
better
least
compar
singleround
realtim
rtpcr
method
diagnosi
clinic
specimen
second
gene
chipbas
diagnosi
highli
specif
requir
hybrid
multipl
sequencespecif
probe
three
virusspecif
three
control
probe
gene
chip
allow
specif
detect
viru
target
one
genom
region
therefor
gene
chip
assay
specif
identifi
sarscov
also
simultan
confirm
diagnosi
one
assay
thu
reduc
falseposit
falseneg
result
contrast
convent
singleround
realtim
rtpcr
detect
one
virusspecif
sequenc
per
reaction
without
stringent
hybrid
probe
third
assay
simpl
rapid
entir
assay
includ
mrtpcr
chipbas
assay
easili
complet
within
h
includ
mrtpcr
follow
gene
chip
analysi
therebi
make
clinic
applic
altern
screen
sarscov
laboratori
equip
realtim
pcr
instrument
although
diagnosi
method
requir
postpcr
process
gene
chip
detect
timeeffici
costeffect
assay
gene
chip
concurr
identifi
viru
target
confirm
diagnosi
result
last
perhap
importantli
one
may
expand
present
gene
chip
simultan
detect
relat
coronavirus
multipl
respiratori
pathogen
one
assay
sar
acut
pneumon
ill
clinic
difficult
distinguish
type
atyp
pneumonia
absenc
clear
epidemiolog
link
patient
diseas
major
advantag
gene
chip
diagnosi
one
add
system
larg
number
altern
pathogen
respons
communityacquir
pneumonia
littl
modif
hand
seem
clear
mrtpcr
primer
suffici
broad
util
design
extens
technolog
simultan
detect
relat
pathogen
serious
hamper
high
effici
viral
copi
number
estim
gene
chip
assay
equal
v
v
b
vial
quantit
perform
describ
previous
figur
correl
viru
titer
determin
chipbas
assay
realtim
nest
pcr
method
viral
rna
concentr
determin
gene
chip
plot
realtim
nest
pcr
correl
coeffici
pcr
amplif
provid
maximum
sensit
detect
low
titer
rna
clinic
specimen
current
expand
content
gene
chip
permit
detect
greater
select
viral
pathogen
semiquantit
assay
gene
chip
design
three
virusspecif
probe
correspond
primer
set
divers
rang
sensit
detect
sarscov
figur
semiquantit
model
success
establish
valid
use
clinic
specimen
resolv
rel
viru
copi
number
taken
togeth
data
suggest
gene
chip
assay
system
readi
clinic
applic
detect
confirm
semiquantifi
viru
earli
sar
infect
